Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1166588 NEW YORK, NY
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,837,131
+$1,836,664 QoQ
Shares Held
188,038
+223754.8% QoQ
Ownership
0.829%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 96 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. KPTI ranks #98 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 4,377,120 $306,529,713
2 REGN
Regeneron Pharmaceuticals, Inc.
 399,847 $249,320,598
3 ARGX
Argenx SE
 157,958 $146,548,693
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 262,258 $130,271,416
5 BNTX
BioNTech SE
 1,319,517 $122,781,056
6 RVMD
Revolution Medicines, Inc.
 552,710 $103,511,528
7 ORKA
Oruka Therapeutics, Inc.
 1,079,015 $102,689,857
8 BBIO
BridgeBio Pharma, Inc.
 1,155,442 $86,057,320

All Filings in KPTI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,837,131 188,038
2026-03-31 $467 84
2025-12-31 $603 82
2025-09-30 $536 82
2025-06-30 $127,735 29,637
2025-03-31 $108,314 28,961
2024-12-31 $888,191 1,313,893
2024-09-30 $1,645,353 1,982,354
2024-06-30 $1,974,001 2,274,195
2024-03-31 $2,678,374 1,773,758
2023-12-31 $1,530,344 1,769,184
2023-09-30 $2,225,603 1,660,898
2023-06-30 $825,361 461,096
2023-03-31 $1,437,763 369,605
2022-12-31 $1,440,308 423,620
2022-09-30 $4,163,359 762,520
2022-06-30 $2,635,138 584,288
2022-03-31 $63,013 8,550
2021-12-31 $92,746 14,424
2021-09-30 $2,725,162 468,241
2021-06-30 $4,052,994 392,732
2021-03-31 $92,828 8,824
2020-12-31 $1,474,965 95,282
2020-09-30 $237,104 16,240
2020-06-30 $201,010 10,613
2020-03-31 $714,419 37,190